New Therapeutics Molecules: Current State of the Art with Case Presentations and Live Q&A
Chairpersons: I. Boukovinas, A. Kyriazoglou
Preclinical drug testing on Xenosarc platform A. Wozniak
Molecular genetics in sarcomas, finding target with therapeutic importance S. Kokkali
Using GIST as a model for new drug development C. Serano